Orders from 120 EUR Free delivery from 250 EUR Ready for pickup dead drop: collect in 5 min Free parcel delivery from 250 EUR

Substances · Lysergamides

1V-LSD

C25H33N3O2 CAS 2767597-51-1 Analytical reference material — not for human consumption
Preferred name
1V-LSD
IUPAC name
(6aR,9R)-N,N-diethyl-7-methyl-4-pentanoyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide
Parent CAS number (reference)
2767597-51-1
Molecular formula
C25H33N3O2
Molecular weight
407.5 g/mol
InChIKey
GIIBVGJWUZNECE-XMSQKQJNSA-N
PubChem
CID 162368540
Source
PubChem
Verified synonyms & catalog abbreviations
1-Valeroyl-LSD Valerie 1VLSD 1V LSD

Matching Listings in This Store's Catalog

Verified Neurochemical & Toxicological Intelligence

1V-LSD

N1-Valeryl Lipophilic Lysergamide Prodrug (5-HT2A Partial Agonist) Lysergamide
Verified PubChem & CAS Identity C25H33N3O2 · CAS 2767597-51-1 · CID 162368540
Calibrated Physical Form Dissolved Liquid Solution (µg Calibrated)
≥98% Analytical Purity Verified 407.5 g/mol
Peer-Reviewed & Agency Citations 2 · verified sources

Receptor Telemetry & Mechanism of Action

5-HT₂ₐ Perceptual & Visual Signaling Partial Agonist
5-HT₁ₐ / 5-HT₂c Serotonergic Modulation Active
D₂ / Adrenergic Dopaminergic / Somatic Tone Moderate

Lipophilic N1-pentanoyl prodrug cleaved in serum to LSD-25 (~79% molar mass equivalent of LSD-25).

Biotransformation & Active Metabolites

Hydrolyzes to LSD and valeric acid in human serum.

Temporal Pharmacokinetics

N1-Valeryl Lipophilic Lysergamide Prodrug (5-HT2A Partial Agonist) — Supplied as dissolved liquid solution; slightly heavier N1-valeryl chain means ~150 ug 1V-LSD corresponds on a molar basis to ~120 ug LSD-25, with a slightly slower onset.

  1. Onset 45–120 min
  2. Peak Window 2.5–4.5 h
  3. Total Window 8–12 h
  4. Residual / Half-Life 4–8 h residual wakefulness

Supplied as dissolved liquid solution; slightly heavier N1-valeryl chain means ~150 ug 1V-LSD corresponds on a molar basis to ~120 ug LSD-25, with a slightly slower onset.

Quantitative Response Spectrum (Published Literature)

Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.

Threshold
20–30 ug
Cognitive & Sensory

Subtle threshold receptor activity (N1-Valeryl Lipophilic Lysergamide Prodrug (5-HT2A Partial Agonist)).

Somatic & Autonomic

Minimal baseline autonomic shift.

Light
30–90 ug
Cognitive & Sensory

Mild, clear-headed expression of primary class profile.

Somatic & Autonomic

Light somatic modulation.

Common Reference
90–175 ug
Cognitive & Sensory

Full characteristic neurochemical and perceptual profile documented in literature.

Somatic & Autonomic

Moderate somatic relaxation, ataxia, or autonomic tone depending on class.

Strong
175–320 ug
Cognitive & Sensory

Pronounced intensity, cognitive/motor impairment, or deep immersion.

Somatic & Autonomic

Marked somatic load and heightened adverse-event sensitivity.

Heavy / Toxic Zone
320+ ug
Cognitive & Sensory

Amnesia, blackout, acute dysphoria, confusion, or anesthetic dissociation.

Somatic & Autonomic

High toxicity zone: severe motor loss, cardiovascular strain, or respiratory hazard.

Interaction Matrix & Critical Contraindications

Critical Hazard — Never Combine

Lithium salts

Strongly documented to provoke acute tonic-clonic seizures, fugue states, and severe psychotic episodes with lysergamides.

Tramadol

Lowers seizure threshold alongside 5-HT2A excitation.

Elevated Hazard — Avoid

Cannabis & Strong Stimulants (Cathinones, Amphetamines, Cocaine)

Exponentially amplifies thought loops, tachycardia, anxiety, and acute paranoia.

Caution / Receptor Attenuation

SSRIs / SNRIs & Benzodiazepines

Chronic SSRIs and acute benzodiazepines markedly attenuate 5-HT2A perceptual effects.

Structural Isomer & Sibling Comparison

Supplied as dissolved liquid solution; slightly heavier N1-valeryl chain means ~150 ug 1V-LSD corresponds on a molar basis to ~120 ug LSD-25, with a slightly slower onset.

Physicochemical Stability & Storage

Form: Clear, colorless calibrated liquid solution for microgram (µg) volumetric measurement. · Supplied pre-dissolved in analytical carrier; sensitive to chlorine/tap water.

Highly sensitive to UV light, heat, and chlorine; store airtight in amber glass under cold/refrigerated conditions.

Cross-Tolerance & Dependence Profile

Immediate rapid 5-HT2A receptor downregulation within hours, cross-tolerant with all tryptamines and phenethylamines; baseline sensitivity typically resets over 10–14 days. Non-addictive physiologically.

Comprehensive Analytical & Toxicological Monograph

1V-LSD ((6aR,9R)-N,N-diethyl-7-methyl-4-pentanoyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide; CAS 2767597-51-1, PubChem CID 162368540) is a lysergamide reference compound (C25H33N3O2, 407.5 g/mol) classified pharmacologically as a N1-Valeryl Lipophilic Lysergamide Prodrug (5-HT2A Partial Agonist). Lipophilic N1-pentanoyl prodrug cleaved in serum to LSD-25 (~79% molar mass equivalent of LSD-25). Hydrolyzes to LSD and valeric acid in human serum. In published observational and toxicological literature, threshold response is noted at 20–30 ug, light range at 30–90 ug, common reference range at 90–175 ug, strong intensity at 175–320 ug, and heavy/adverse territory at 320+ ug, with an onset of 45–120 min, peak window of 2.5–4.5 h, and total duration of 8–12 h (4–8 h residual wakefulness). Supplied as dissolved liquid solution; slightly heavier N1-valeryl chain means ~150 ug 1V-LSD corresponds on a molar basis to ~120 ug LSD-25, with a slightly slower onset. Critical contraindications include Lithium salts, Tramadol.

Chemical Architecture & Structural Profile

1V-LSD ((6aR,9R)-N,N-diethyl-7-methyl-4-pentanoyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide) is a reference compound belonging to the Lysergamides class, characterized by the molecular formula C25H33N3O2 and a molar mass of 407.5 g/mol. The parent molecule is indexed under CAS registry number 2767597-51-1 and in the NCBI PubChem database as CID 162368540 (Standard InChIKey: GIIBVGJWUZNECE-XMSQKQJNSA-N).

Citations

Reference Toxicology & Safety Profile

In documented chemical and harm-reduction literature (PubChem / PsychonautWiki, CC BY 4.0), 1V-LSD is indexed within the Lysergamides structural group. Toxicological notes (PsychonautWiki): extremely low toxicity relative to dose. Dependence liability (PsychonautWiki): non-addictive with a low abuse potential. Documented cross-tolerance class: psychedelic. Standard laboratory handling precautions—including nitrile gloves, eye protection, and local exhaust ventilation—apply whenever handling the reference material.

Citations

Analytical Use & Laboratory Notice

This reference sheet provides chemical, analytical, and toxicological provenance only. The material is strictly not for human consumption, diagnostic, or veterinary use. Research-use labelling does not establish legal status in any jurisdiction.

Citations

Documented Contraindications & Interactions

High-risk / Dangerous combinations

Unsafe combinations (elevated hazard)

Uncertain combinations (caution advised)